(UroToday.com) The 2022 EAU Section of Oncological Urology (ESOU) Annual Meeting included a session on urothelial cancer and a presentation by Dr. Valeria Panebianco discussing how magnetic resonance imaging (MRI) has changed the bladder cancer pathway. Dr. Panebianco notes that for more than 30 years the diagnostic pathways for bladder cancer patients have remained largely unchanged, with TURBT as the initial diagnostic and staging tool. However, there are TURBT-related issues, such as understaging and residual tumor (~58%), which are often secondary to operator-dependent performance (experience, judgement, skill).